Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg

Pfizer

Status: Completed

Conditions: Rheumatoid Arthritis

Treatments: Drug: etanercept

Study type: Observational

Funder types: Industry

Identifiers

NCT00195338

0881-101343

Details and patient eligibility

About

The purpose of the study is to determine the long term safety of Enbrel in adults with active rheumatoid arthritis in Luxemburg. This is a post-marketing surveillance study in rheumatology practice patients. All patients initiated with Enbrel will be observed from the start of the study in Feb 2003 for a period of at least 5 years.

Enrollment: 25 patients

Sex: All

Ages: 17+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Have moderate to severe active rheumatoid arthritis
• Be aged of 17 years or more
• Have inadequate response to DMards
• Give written informed consent
• Physician decides to prescribe Enbrel

Exclusion criteria

n/a

Trial design

25 participants in 1 patient group

1

Description:

This is an open label, observational study.This is a post-marketing surveillance study in rheumatology practice patients in Luxemburg.Rheumatologists will be asked to document safety and adherence to therapy of Enbrel when given to adults with active rheumatoid arthritis.All patients initiated with Enbrel will be observed.

Treatment:

Drug: etanercept